US 4631837A
· Magoon
· 1986
[cited by applicant]
US 6552017B1
· Robichaud et al.
· 2003
[cited by applicant]
US 6713471B1
· Robichaud et al.
· 2004
[cited by applicant]
US 7071186B2
· Robichaud et al.
· 2006
[cited by applicant]
US 7183282B2
· Robichaud et al.
· 2007
[cited by applicant]
US RE39680E
· Robichaud et al.
· 2007
[cited by applicant]
US 7357891B2
· Yang et al.
· 2008
[cited by applicant]
US 7425292B2
· Yang et al.
· 2008
[cited by applicant]
US 7666337B2
· Yang et al.
· 2010
[cited by applicant]
US 8012505B2
· Houghton et al.
· 2011
[cited by applicant]
US 8017150B2
· Yang et al.
· 2011
[cited by applicant]
US 8309722B2
· Tomesch et al.
· 2012
[cited by applicant]
US 8598119B2
· Mates et al.
· 2013
[cited by applicant]
US 8603514B2
· Yang et al.
· 2013
[cited by applicant]
US 8648077B2
· Tomesch et al.
· 2014
[cited by applicant]
US 8652378B1
· Yang et al.
· 2014
[cited by applicant]
US 8663667B2
· Bui et al.
· 2014
[cited by applicant]
US 8765167B2
· Myers et al.
· 2014
[cited by applicant]
US 8779139B2
· Tomesch et al.
· 2014
[cited by applicant]
US 8900497B2
· Yang et al.
· 2014
[cited by applicant]
US 8900498B2
· Yang et al.
· 2014
[cited by applicant]
US 8936825B2
· Myers et al.
· 2015
[cited by applicant]
US 8956685B2
· Bogue et al.
· 2015
[cited by applicant]
US 8993572B2
· Mates et al.
· 2015
[cited by applicant]
US 9108340B2
· Yang et al.
· 2015
[cited by applicant]
US 9168258B2
· Mates et al.
· 2015
[cited by applicant]
US 9315504B2
· Tomesch et al.
· 2016
[cited by applicant]
US 9371324B2
· Mates et al.
· 2016
[cited by applicant]
US 9428506B2
· Mates et al.
· 2016
[cited by applicant]
US 9586960B2
· Tomesch et al.
· 2017
[cited by applicant]
US 9616061B2
· Mates et al.
· 2017
[cited by applicant]
US 9708322B2
· Li et al.
· 2017
[cited by applicant]
US 9745300B2
· Mates et al.
· 2017
[cited by applicant]
US 9751883B2
· Tomesch et al.
· 2017
[cited by applicant]
US 9855221B2
· Myers et al.
· 2018
[cited by applicant]
US 9931305B2
· Yang et al.
· 2018
[cited by applicant]
US 20040034015A1
· Robichaud et al.
· 2004
[cited by applicant]
US 20040228919A1
· Houghton et al.
· 2004
[cited by applicant]
US 20050037055A1
· Yang et al.
· 2005
[cited by applicant]
US 20050281772A1
· Bromley et al.
· 2005
[cited by applicant]
US 20120219628A1
· Lim et al.
· 2012
[cited by applicant]
US 20120263865A1
· Bogue
· 2012
[cited by applicant]
US 20130156823A1
· Wu et al.
· 2013
[cited by applicant]
US 20140178473A1
· Lim et al.
· 2014
[cited by applicant]
US 20150072964A1
· Mates et al.
· 2015
[cited by applicant]
US 20150080404A1
· Mates et al.
· 2015
[cited by applicant]
US 20160310502A1
· Vanover et al.
· 2016
[cited by applicant]
US 20170056374A1
· Lee et al.
· 2017
[cited by applicant]
US 20170114037A1
· Davis et al.
· 2017
[cited by applicant]
US 20170183350A1
· Mates et al.
· 2017
[cited by applicant]
US 20170189398A1
· Mates et al.
· 2017
[cited by applicant]
US 20170290776A1
· Schobel et al.
· 2017
[cited by applicant]
US 20170348251A1
· Schobel et al.
· 2017
[cited by applicant]
US 20170360942A1
· Myers et al.
· 2017
[cited by applicant]
US 20180280518A1
· Myers et al.
· 2018
[cited by applicant]
US 20200000773A1
· Lee et al.
· 2020
[cited by applicant]
US 20200046637A1
· Lim et al.
· 2020
[cited by applicant]
US 20230086496A1
· Lim et al.
· 2023
[cited by applicant]
CN 1758899A
· 2006
[cited by applicant]
CN 102933207A
· 2013
[cited by applicant]
CN 105193772A
· 2015
[cited by applicant]
JP 2013253039A
· 2013
[cited by applicant]
WO 2004075875A1
· 2004
[cited by applicant]
WO 2011053251A1
· 2011
[cited by applicant]
WO 2017192923A1
· 2017
[cited by applicant]
Aprea, E. et al., “Volatile Compounds of Raspberry Fruit: From Analytical Methods to Biological Role and Sensory Impact,” Molecules 2015, vol. 20, 2445-2474.
[cited by applicant]
Pion Rainbow Dynamic Dissolution Monitor (https://pion.com.cn/dissolution/compendial-dissolution/rainbow/) (5 pages).
[cited by applicant]
International Search Report issued in PCT/US2019/049725, dated Jan. 28, 2020 (5 pages).
[cited by applicant]
Written Opinion of the International Searching Authority issued in PCT/US/2019/049725, dated Jan. 28, 2020 (5 pages).
[cited by applicant]
Rajni Bala et al., Design Optimization and In Vitro-In Vivo Evaluation of Orally Dissolving Strips of Clobazam, 2014, Journal of Drug Delivery, vol. 2014, Article ID 392783, pp. 1-15 (Year: 2014).
[cited by applicant]
Pharmaceutics, Meng Shengnan et al., Shanghai Scientific & Technical Publishers, pp. 81-83, published on Sep. 30, 2011.
[cited by applicant]
First Office Action for Chinese Application No. 201980073077.2 dated Apr. 20, 2023 (in Chinese with English translation).
[cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 19 797 393.3-1112 dated Mar. 28, 2023.
[cited by applicant]
Preliminary Office Action for Brazilian Patent Application No. BR112021004053-6 dated Jun. 5, 2023 (in Portuguese with Informal English Translation).
[cited by applicant]
Official Action (Dispatch Date: Jul. 6, 2023) for Japanese Patent Application No. 2021-512652 in Japanese with English Summary of the Official Action.
[cited by applicant]
Official Action (Dispatch Date: Jul. 6, 2023) for Japanese Patent Application No. 2021-512652 in Japanese with English machine translation.
[cited by applicant]
Foo, Wen Chin et al., A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film, Int J Pharm. Mar. 25, 2018;539(1-2): 165-174. doi: 10.1016/j. ijpharm.2018.01.047.Epub Feb. 27, 2018.
[cited by applicant]
International Preliminary Report on Patentability (Chapter I) issued by the International Bureau of WIPO on behalf of the International Searching Authority for International application No. PCT/US2019/049725, Date of is…
[cited by applicant]
Communication pursuant to Article 94(3) EPC from the European Patent Office for European Patent Application No. 19 797 399.3-1112 dated Mar. 28, 2023.
[cited by applicant]
Second Office Action issued by the China National Intellectual Property Administration for Chinese Application No. 201980073077.2 dated Dec. 7, 2023 (in Chinese with English translation).
[cited by applicant]
Decision on Rejection issued by the China National Intellectual Property Administration for Chinese Application No. 201980073077.2 dated May 9, 2024 (in Chinese with English translation).
[cited by applicant]
Office Action issued by the Canadian Intellectual Property Office (CIPO) dated Dec. 8, 2023 for Canadian Patent Application No. 3,110,997.
[cited by applicant]
Official Action (Dispatch Date: Apr. 25, 2024) issued by the Japan Patent Office for Japanese Patent Application No. 2021-512652 (in Japanese with English machine translation and with a Brief summary of Official Action …
[cited by applicant]
Office Action issued in U.S. Appl. No. 16/561,573, mail date Jun. 22, 2021.
[cited by applicant]
Office Action issued in U.S. Appl. No. 16/561,573, mail date Apr. 12, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/989,307, mail date Jun. 3, 2024.
[cited by applicant]
Pre-grant Opposition Petition filed Feb. 28, 2024 with the National Institute of Industrial Property—INPI by EMS S.A. for Brazilian Patent Application No. BR 11 2021 004053 6 (in Portuguese with English Translation).
[cited by applicant]
Pre-grant Opposition Petition filed Sep. 20, 2024 with the National Institute of Industrial Property—INPI by Biolab Sanus Farmacêutica LTDA. for Brazilian Patent Application No. BR 11 2021 004053 6 (in Portuguese with E…
[cited by applicant]
Shen, Bao-De et al., Development and characterization of an orodispersible film containing drug nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol. 85, Issue 3, Part B, Nov. 2013, pp. 1348-1356, …
[cited by applicant]
English Summary of Official Action (Dispatch Date: Jul. 6, 2023) for Japanese Patent Application No. 2021-512652.
[cited by applicant]
Communication pursuant to Article 94(3) EPC from the European Patent Office for European Patent Application No. 19 797 399.3-1109 dated Dec. 4, 2024.
[cited by applicant]
Office Action issued by the Canadian Intellectual Property Office (CIPO) dated Feb. 6, 2025 for Canadian Patent Application No. 3,110,997.
[cited by applicant]